Researchers in Chile and France mapped 71,857 peptide sequences to a shared toxicity vocabulary, aiming to make early drug screening more reliable.
Recap by typeshit. Full story at BIOENGINEER.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
Robert Lufkin MD shares the observational data: an average 16.1 kg lost at six months among 7,297 women, with 62.7% reporting side effects.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Viking's oral weight loss candidate VK2735 has moved into late-stage testing, putting another pill in the race against Lilly and Novo.
The American Journal of Obstetrics and Gynecology published a review on how GLP-1 receptor agonists and birth control use overlap.
Loading…